Ibutin

Trimebutine, the active ingredient in Ibutin, is a prokinetic / spasmolytic presented as an oral tablet for oral use. It treats functional gastrointestinal disorders such as irritable bowel syndrome, functional dyspepsia and gastrointestinal spasm in adult patients.

GNH USA supplies Ibutin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Trimebutine is used to manage disorders of gastrointestinal motility and spasm.

Irritable bowel syndrome: alleviates abdominal pain and normalizes bowel habits. Functional dyspepsia: reduces post‑prandial discomfort and improves gastric emptying. Gastrointestinal spasm: relieves acute intestinal cramping and smooth‑muscle hyperactivity.

Trimebutine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild transient nausea. - Abdominal discomfort: occasional mild cramping. - Diarrhea: loose stools. - Headache: occasional headache.

Serious or Rare Side Effects: - Allergic reactions: rash, pruritus, or angioedema. - Hepatotoxicity: elevated liver enzymes in rare cases. - Cardiac arrhythmia: rare conduction disturbances.

Before prescribing Trimebutine, consider the following precautions.

Pregnancy: safety not established; avoid unless benefit outweighs risk. Breastfeeding: unknown excretion; monitor infant for adverse effects. Renal impairment: dose may require adjustment; monitor renal function. Hepatic impairment: use with caution; periodic liver‑function tests recommended. Concomitant opioid use: may enhance opioid‑related effects; observe closely. Store at ambient temperature: keep below 25°C, retain in original packaging and protect from moisture.

Trimebutine can interact with other medicines; some interactions require avoidance while others need monitoring.

Major Interactions (Avoid): - Anticholinergic agents: may diminish prokinetic efficacy. - Strong CYP3A4 inhibitors (e.g., ketoconazole): increase plasma concentrations. - Potent opioids: additive opioid effects may occur.

Moderate Interactions (Monitor Closely): - Tricyclic antidepressants: may increase gastrointestinal side effects. - Antidiarrheal agents (e.g., loperamide): may counteract therapeutic action. - Antacids: may affect absorption; separate administration recommended.